Sensitivity Analyses Comparing Time-to-Event Outcomes Only Existing in a Subset Selected Postrandomization and Relaxing Monotonicity

Biometrics

Volumn 67, Issue 3, 2011, Pages 1100-1110

  Shepherd, Bryan E ^a   Gilbert, Peter B ^b   Dupont, Charles T ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Causal inference; HIV; Kaplan Meier; Monotonicity; Principal stratification

Indexed keywords

RANDOM PROCESSES; SENSITIVITY ANALYSIS;

ANALYSIS APPROACH; ANTIRETROVIRALS; CAUSAL INFERENCES; HIV; KAPLAN-MEIER; MONOTONICITY; PRINCIPAL STRATIFICATION; RANDOMISATION; SENSITIVITY ANALYZES; TIME TO EVENTS;

VACCINES;

DISEASE TREATMENT; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIVITY; SENSITIVITY ANALYSIS; VACCINE;

EID: 80052811150     PISSN: 0006341X     EISSN: 15410420     Source Type: Journal    
DOI: 10.1111/j.1541-0420.2010.01508.x     Document Type: Article

References (24)

1. Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., Del Rio, C., McElrath, M. J., Casimiro, D. R., Gottesdiener, K. M., Chodakewitz, J. A., Correy, L., Robertson, M. N., and the Step Study Protocol Team. (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893.
2. Cox, D. R. (1958). Planning of Experiments. New York: Wiley.
3. Flynn, N. M., Forthal, D. N., Harro, C. D., Judson, F. N., Mayer, K. H., Para, M. F., and the rgp120 HIV Vaccine Study Group. (2005). Placebo controlled phase 3 trial of a recombinant glycoprotein 120 vaccine to prevent HIV-1 infection. Journal of Infectious Diseases 191, 647-649.
4. Frangakis, C. E. and Rubin, D. B. (2002). Principal stratification in causal inference. Biometrics 58, 21-29.
5. Gilbert, P. B., Bosch, R. J., and Hudgens, M. G. (2003). Sensitivity analysis for the assessment of causal vaccine effects on viral load in HIV vaccine trials. Biometrics 59, 531-541.
6. Graham, B. S. (2002). Clinical trials of HIV vaccines. Annual Review of Medicine 53, 207-221.
7. Horne, A. D., Lachenbruch, P. A., and Goldenthal, K. L. (2000). Intent-to-treat analysis and preventive vaccine efficacy. Vaccine 19, 319-326.
8. Hudgens, M. G., Hoering, A., and Self, S. G. (2003). On the analysis of viral load endpoints in HIV vaccine trials. Statistics in Medicine 22, 2281-2298.
9. Jemiai, Y. (2005). Semiparametric methods for inferring treatment effects on outcomes defined only if a post-randomization event occurs. Unpublished Ph.D. dissertation under the supervision of A. Rotnitzky, Harvard School of Public Health, Department of Biostatistics.
10. Joffe, M. M., Small, D., and Hsu, C. Y. (2007). Defining and estimating intervention effects for groups that will develop an auxiliary outcome. Statistical Science 22, 74-97.
11. Neyman, J. (1923). On the application of probability theory to agricultural experiments: Essay on principles. Translated in Statistical Science 5, 465-480.
12. Liu, J. S. (2001). Monte Carlo Strategies in Scientific Computing. New York: Springer-Verlag.
13. Mehrotra, D. V., Li, X., and Gilbert, P. B. (2006). A comparison of eight methods for the dual-endpoint evaluation of efficacy in a proof-of-concept HIV vaccine trial. Biometrics 62, 893-900.
14. Robins, J. M. (1986). A new approach to causal inference in mortality studies with sustained exposure periods-application to control of the healthy worker survivor effect. Mathematical Modeling 7, 1393-1512.
15. Robins, J., Rotnitzky, A., and Vansteelandt, S. (2007). Discussion of "Principal stratification designs to estimate input data missing due to death" by Frangakis CE, Rubin DB, An MW, and MacKenzie E. Biometrics 63, 650-651.
16. Rosenbaum, P. R. (1984). The consequences of adjustment for a concomitant variable that has been affected by the treatment. Journal of the Royal Statistical Society, Series A 147, 656-666.
17. Rubin, D. B. (1978). Bayesian inference for causal effects: The role of randomization. The Annals of Statistics 6, 34-58.
18. Scharfstein, D. O., Rotnitzky, A., and Robins, J. M. (1999). Adjusting for nonignorable drop-out using semiparametric nonresponse models. Journal of the American Statistical Association 94, 1096-1146.
19. Shepherd, B. E., Gilbert, P. B., Lumley, T. (2007). Sensitivity analyses comparing time-to-event outcomes only existing in a subset selected post-randomization. Journal of the American Statistical Association 102, 573-582.
20. Shepherd, B. E., Gilbert, P. B., Mehrotra, D. V. (2007). Eliciting a counterfactual sensitivity parameter. The American Statistician 61, 56-63.
21. Shepherd, B. E., Redman, M. W., and Ankerst, D. P. (2008). Does finasteride affect the severity of prostate cancer? A causal sensitivity analysis. Journal of the American Statistical Association 484, 1392-1404.
22. Thior, I., Lockman, S., Smeaton, L. M., Shapiro, R. L., Wester, C., Heymann, S. J., Gilbert, P. B., Stevens, L., Peter, T., Kim, S., van Widenfelt, E., Moffat, C., Ndase, P., Arimi, P., Kebaabetswe, P., Mazonde, P., Makhema, J., Mclntosh, K., Novitsky, V., Lee, T. H., Marlink, R., Lagakos, S., Essex, M., and the Mashi Study Team. (2006). Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: A randomized trial: the Mashi Study. Journal of the American Medical Association 296, 794-805.
23. von Neumann, J. (1951). Various techniques used in connection with random digits. National Bureau of Standards Applied Mathematics Series 12, 36-38.
24. Zhang, J. L. and Rubin, D. B. (2003). Estimation of causal effects via principal stratification when some outcomes are truncated by "death." Journal of Educational and Behavioral Statistics 28, 353-368.